# Self-Start Triage Model for Post-Botox® Lower Urinary Tract Symptoms

> **NCT07648290** · EARLY_PHASE1 · RECRUITING · sponsor: **The Cleveland Clinic** · enrollment: 260 (estimated)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Macrobid® Capsules 100 mg
- **OTHER:** Standard Medical Care (SMC)

## Key facts

- **NCT ID:** NCT07648290
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-31
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2026-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07648290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07648290, "Self-Start Triage Model for Post-Botox® Lower Urinary Tract Symptoms". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07648290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*